Benitec raises $3.75m, launches share purchase plan
Monday, 08 November, 2004
Gene silencing specialist Benitec (ASX:BLT) has raised AUD$2.75 million in a placement to institutions and 'sophisticated' investors in Australia and abroad, the company said today.
And it has opened a share purchase plan to shareholders, offering up to $4950 of fully-paid ordinary shares at $0.55, a 14.9 per cent discount to Benitec's volume-weighted average price over the last five days.
In a statement, the company said it would use the funds raised for a variety of activities, including expanding its US facilities, US management team and RNAi intellectual property, reviewing M&A opportunities, and developing its cancer program.
Farm animals and aquaculture cryopreservation partnership announced
Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
